Free Trial

Sernova Corp. (OTCMKTS:SEOVF) Short Interest Up 36.8% in September

Sernova logo with Medical background

Sernova Corp. (OTCMKTS:SEOVF - Get Free Report) was the target of a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 43,100 shares, an increase of 36.8% from the August 31st total of 31,500 shares. Based on an average trading volume of 69,900 shares, the days-to-cover ratio is presently 0.6 days.

Sernova Price Performance

Sernova stock remained flat at $0.18 during midday trading on Friday. 3,766 shares of the company's stock traded hands, compared to its average volume of 36,992. The company has a fifty day simple moving average of $0.19 and a 200-day simple moving average of $0.26. Sernova has a twelve month low of $0.15 and a twelve month high of $0.61. The company has a market capitalization of $54.65 million, a P/E ratio of -2.00 and a beta of 1.18. The company has a debt-to-equity ratio of 0.14, a quick ratio of 0.32 and a current ratio of 0.32.

Sernova (OTCMKTS:SEOVF - Get Free Report) last issued its quarterly earnings results on Monday, September 16th. The company reported ($0.01) earnings per share (EPS) for the quarter.

About Sernova

(Get Free Report)

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Sernova right now?

Before you consider Sernova, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sernova wasn't on the list.

While Sernova currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

AST SpaceMobile Takes Major Leap in Global Connectivity with Satellite Launch
Why Congress Is Betting Big on Broadcom in 2024
What the Bulls and Bears Are Saying About NVIDIA Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines